SCHEMBL33523810

SCHEMBL33523810

Ic1cc2ccccc2c(-c2cccc3ccccc23)c1I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALPL P05186 1/20 0.42
GAA P10253 1/20 0.42
GPR84 Q9NQS5 1/20 0.42
ALDH1A1 P00352 3/20 0.40
HSD17B10 Q99714 3/20 0.40
HIF1A Q16665 2/20 0.40
TSHR P16473 2/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DHFR P00374 1/20 0.39
CYP1B1 Q16678 1/20 0.39
PTPN1 P18031 1/20 0.39
TYMP P19971 1/20 0.38
DNMT1 P26358 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29202921 1.00 CES1 (0.42) CES1KDM4EALPLGAAGPR84
SCHEMBL30311473 0.82 GPR84 (0.43) CES1KDM4EALPLGAAGPR84
SCHEMBL338172 0.80 CES1 (0.55) CES1KDM4EALPLGAAGPR84
SCHEMBL25012509 0.79 KDM4E (0.40) KDM4EALPLGAAGPR84ALDH1A1
SCHEMBL9756475 0.79 DNMT1 (0.46) CES1KDM4EALPLGAAGPR84
SCHEMBL30037009 0.76 CES1 (0.52) CES1KDM4EALPLGAAGPR84
SCHEMBL13445530 0.76 DHFR (0.43) KDM4EALPLGAAALDH1A1HSD17B10
SCHEMBL7243627 0.76 CES1 (0.52) CES1KDM4EALPLGAAGPR84
SCHEMBL27263879 0.75 ALDH1A1 (0.53) KDM4EALPLGAAALDH1A1HSD17B10
SCHEMBL29663473 0.75 GPR84 (0.53) CES1KDM4EALPLGAAGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260093175-A1 RESIST COMPOSITION, LAMINATE, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260093175-A1 RESIST COMPOSITION, LAMINATE, AND PATTERNING PROCESS ITGB4, ITGA4, IRS1 CES1 1411/4885KDM4E 396/4885ALPL 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.